Qu
Quanta Ther
S San Francisco CAFounded 201930 employees
Private CapbiotechPrivateOncology
Platform: Gamma-delta T
Market Cap
N/A
All Drugs
4
Clinical Trials
7
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Suraglumide | QUA-4280 | Phase 1 | 2 | MALT1 | Pompe | ||
| QUA-2029 | QUA-2029 | Phase 1/2 | 2 | PRMT5 | PVGBM | ||
| QUA-617 | QUA-617 | Phase 1 | 2 | SMN2 | ACCSMA | ||
| Polatinib | QUA-8936 | Phase 2 | 1 | Tau | MCCRett |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)